Wereport a 51-year-old womanwith polymyositis accompanied by a high titer of antiacetylcholine receptor antibody. The patient presented with weakness of grip strength followed by rapidly progressive dyspnea, which required mechanical ventilation. She was treated with a glucocorticoid and cameoff the respirator one weeklater. Antiacetylcholine receptor antibody activity waselevated in the acute phase and decreased during recovery, although other signs of myasthenia gravis were negative. This patient suggested that in cases of rapidly progressive bulbar palsy and limb muscle weakness, it is necessary to include polymyositis associated with elevated antiacetylcholine receptor antibody activity in the differential diagnosis.
Introduction
Polymyositis is defined as idiopathic inflammatory changes in muscles. Bohan and Peter proposed four major criteria to diagnose polymyositis: symmetrical weakness of the limbgirdle muscles and anterior neck flexors progressing over weeks or months, muscle-biopsy evidence, elevation of serum skeletal-muscle enzymes,and an electromyographicabnormality (1) . However, the course of this disease is heterogeneous, and the pathogenesis remains unclear. Themeasurementof myositis-specific autoantibodies maybe useful for predicting the clinical course and treatment (2) . On the other hand, myasthenia gravis is characterized by fluctuating muscle weakness. Results from an edrophonium (Tensilon) test, electromyography and a serum antiacetylcholine receptor antibody (anti-Ach R Ab) assay are diagnostic. Although the clinical profile and pathogenesis are quite different between polymyositis and myasthenia gravis, they share features as autoimmunediseases, e.g., the presence of autoantibodies, the fluctuating course of the disease, the association with other autoimmunedisorders, and the effectiveness of corticosteroid therapy. Moreover, polymyositis is, though less frequently, accompanied by myasthenia gravis. Weobserved a patient with rapidly progressive polymyositis with an increased activity of anti-Ach R Ab. The purpose of this study was to showhowthis antibody activity was related to the patient' s clinical profile.
Case Report A 5 1-year-old womanhad been well until she had difficulty squeezing towels in April 1998. A few days later, she could not stand up by herself and had dysphagia. Two weeks later, she was admitted to a hospital in Chiba Prefecture. A brain computerized tomography (CT) scan revealed no abnormal densities. Laboratory tests disclosed slightly elevated C-reactive protein and aspartate aminotransferase. Because the dyspnea and dysphagia worsened, she wastransferred to our hospital onMay ll.
On physical examination, the patient was alert. She had a low grade fever. Noskin rash was found. The neurological examination showed limb muscle weakness. Her grip strength was 4 kg on both sides. Muscle strength test demonstrated diffuse weakness of the upper extremities (biceps brachii, 3) and proximal dominant weakness of the lower extremities (iliopsoas, 2; quadriceps femoris, 4). Her deep tendon reflexes were diminished. In addition, there was tenderness on the thigh.
On the laboratory tests (Table 1) , arterial blood gases showed acute respiratory failure: pH 7.403; pCO2 54. 1 mmHg; pO2 58.2 mmHg;and HCO3" 33.7 mEq/l. Creatine kinase (CK) was elevated to 695 IU// (normal 31-186 ). Anti-Jo-1 antibody, antinuclear antibody and anti-RNP antibody were all negative. Antiganglioside antibodies were also negative. Anti-Ach R Abactivity was elevated to 77.0 nmol// (normal, less than 0.2 nmol/ ml). A lumbar puncture performed on May ll showed a total Rapidly Progressive Polymyositis The grip strength did not recover following the edrophonium (10 mg) intravenous injection. Needle electromyography on the right biceps brachii muscle showed fibrillation and positive sharp waves at rest, and short-duration, low-amplitude motor unit action potentials during voluntary contraction. Repetitive nerve stimulation in the right abductor pollicis brevis muscle (median nerve) and the left upper trapezius muscle (spinal accessory nerve) showed no significant reduction in action potentials. Thenerve conduction velocity was normal, though the F wave amplitude and the frequency of the right median nerve were slightly reduced. These findings suggested the presence of polymyositis. The muscle biopsy specimen showed perivascular and interstitial inflammatory cell infiltration (lymphocyte and macrophage) and degeneration and regeneration of muscle fibers with a phagocytic reaction, which were consistent with the findings of polymyositis (Fig. 1) . Interstitial lymphocyte infiltration is also observed in myasthenia gravis (knownas "lymphorrhages"). However, the coexistence of perivascular cell infiltration and degeneration and regeneration of muscle fibers with a phagocytic reaction differed from the findings of myasthenia gravis. A thoracic CT scan on May 21 revealed a nodule (1 cm in diameter) on the anterior mediastinum. A CT-guided percutaneous needle biopsy specimen showednecrotic tissue without thymomaor malignant cells. The patient needed mechanical ventilation immediately after the admission. Because the acute- men established the diagnosis of polymyositis. The CKlevel became normalized and the bulbar palsy recovered in a few days. She came off the respirator on May20 and was able to eat without effort on May27. The three-day pulse therapy was performed three times (May 16, 23 and 30) followed by oral prednisolone at a dose of 30 mg per day, which was tapered to 10 mgover the next twomonths. Her muscle weaknessimproved and she was able to stand up and walk by herself one month after the corticosteroid therapy. However, the grip strength remained reduced until one and a half years later. The diminished deep tendon reflexes were partially recovered three months later. Anti-Ach R Ab activity was reduced to 6.8 nmol/ / on June 25 and 2.1 nmol// on July 5, but it was elevated slightly to ll nmol// two years later when prednisolone had been tapered off. A follow-up CT scan did not show enlargement of the mediastinumnodule one and a half years after onset.
Discussion
This patient had two distinct features. One was the acuteonset and rapidly-progressive clinical course of the disease, and the other was elevated anti-Ach R Abactivity. The diagnosis of polymyositis for this patient was based on the bilateral limb muscle weakness, the elevation of CK,electrophysiological findings, and the pathology of the muscle biopsy specimen. These findings fulfilled the criteria described by Bohan and Peter (1). Of note is that the anti-Ach R Ab activity was extraordinarily increased in the acute phase and reduced one and a half months later when she could walk by herself. Increased antiAch R Ab activity is specific to myasthenia gravis (3). Severe necrotizing and inflammatory changes in biopsied muscle may also be found in myasthenia gravis (4, 5) . In this patient, however, the edrophoniumtest wasnegative and repetitive nerve stimulation did not show waning of muscle action potentials. Thus this patient did not have accompanying myasthenia gravis, although it is possible that other typical symptoms of myasthenia gravis may appear in the future. According to previous reports of myasthenia gravis, the association ofpolymyositis varies from 0.3% to 1.0% (6). Namba et al (7) reviewed 21 cases of polymyositis with some features of myasthenia gravis. In these cases, the muscle strength response to anticholinesterase compounds wasequivocal or partial in 13 patients, and absent in two. Electrophysiologic evidence of myasthenia gravis was found in only two of nine patients. However, anti-Ach R Ab activity was not reported. Thus, howanti-Ach R Abactivity affects or modifies the clinical profile of polymyositis remains unknown. The rapid progress of bulbar palsy and limb muscle weakness, the reduced deep tendon reflexes and only slightly elevated serum CK more closely mimicked the clinical profile of Guillain-Barre syndrome than that of polymyositis. It is questionable, however, that such a slight elevation of CKcould explain the severe muscleweakness. Theaccompaniment of Guillain-Barre syndrome was deniable, based on the examinations of the cerebrospinal fluid and the serum anti-ganglioside antibodies. On the other hand, it is hard to conceive that such a high level of anti-Ach R Ab (more than 380-fold the normal value and seven times higher than in the recovery stage) merely accompanied the disease. This level of anti-Ach R Ab concentration seemed to be enough to produce symptoms, compared with that of the reported patients with polymyositis and myasthenia gravis (6, 8, 9) . We believe that elevated anti-Ach R Ab had somecorrelation with the acute-onset and rapidly-progressive muscular weaknessof the patient. Somemyositis-specific autoantibodies have been reported: anti-Jo-1 and other anti-aminoacyl-tRNA synthetase antibodies, anti-signal recognition particle antibodies, and anti-Mi-2 antibodies. These antibodies have been proven to be associated with the symptoms, clinical course, and responses to the therapy and prognosis (2), although anti-Jo-1 antibody was negative in our patient. It is not clear whether the high level of anti-Ach R Ab had a direct effect on the patient's muscle weakness or not. However, it is possible to assume that the present patient had a defect in immunoregulation, as revealed by the elevated anti-Ach R Ab titer, and there were some humoral or cellular immuneinteraction between the production of antiAch R Ab and the inflammatory change of polymyositis, which resulted in rapid progression of the disease. In conclusion, this patient suggested that in cases of rapidly progressive bulbar palsy and limb muscle weakness, it is necessary to include polymyositis associated with elevated antiAch R Ab activity in the differential diagnosis. Further studies are required to determine the contribution of anti-Ach R Abto the inflammatory process of muscles and also to the muscle weakness.
